Trials / Completed
CompletedNCT03177655
Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University of California, San Diego · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This single-center interventional study quasi-randomly allocated patients to a guided imagery or control intervention (positive journaling). Data were analyzed with treatment allocation masked.
Detailed description
Interventions: Participants were assigned in alternate order to 10 weekly 1-hour sessions "Healing Light Guided Imagery" or at-home positive journaling; drop-outs were replaced. Intervention Type: Behavioral Multiple sclerosis (MS) is an autoimmune disease that affects the brain and spinal cord (central nervous system). Because nerves in any part of the brain or spinal cord may be damaged, patients with multiple sclerosis can have symptoms in different parts of the body. Many Multiple Sclerosis patients suffer from depression, fatigue and anxiety in addition to physical symptoms. Drugs prescribed for MS have been shown to not improve these comorbid psychological symptoms. Researchers have shown that mindfulness-based training programs can help MS patients, but these therapies are highly resource demanding and taxing for those involved. "Healing Light" Guided Imagery (HLGI; supplementary materials) is a guided imagery therapy that simulates a self-hypnotic trance state that has been anecdotally shown to improve depression and fatigue in patients with MS in less time and with fewer support resources. The investigators plan to test whether HLGI can increase patient well-being.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Guided Imagery | Guided Imagery meditation |
| OTHER | Journaling | Keeping a journal |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2017-03-01
- Completion
- 2017-03-01
- First posted
- 2017-06-06
- Last updated
- 2017-06-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03177655. Inclusion in this directory is not an endorsement.